In this podcast I review “Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess” Talan et al NEJM 2016;374:823-32 and see what the clinical advantage to adding TM-SMX to simple I&D. Then we take a quick turn to some Tox and look at “Extracorporeal membrane oxygenation in the treatment of poisoned patients” deLange et al in Clinical Toxicology 2013;51:385-393.
4XTRIM SULFA BID and MRSA Abscess
Okay so – so it’s a little weird to have those two – but hey that’s what I am reading…
Enjoy and let me know what you think
The Hot Stove League of EM/Tox 